Future Directions in the Management of Non-melanoma Skin Cancer
The current and future management of non-melanoma skin cancer (NMSC)—predominantly basal cell carcinoma (BCC) and squamous cell carcinoma (SCC)—represents a significant public health problem worldwide. Australia has one of the highest rates of skin cancer in the world, with data showing that NMSC is five times more common than all other cancers combined . The sun-exposed head and neck (HN) is the most common location, with incidence rates continuing to rise 3–10 % per year. Although BCC is more common, the vast majority of NMSCs are localized and easily treated with simple excision. However, 5 % are considered high-risk (nearly always SCC) and metastasize to regional lymph nodes with the potential for distant spread .
KeywordsNeck Dissection Basal Cell Carcinoma Merkel Cell Carcinoma Epithelial Growth Factor Receptor Basal Cell Nevus Syndrome
- 7.Australian Institute of Health and Welfare (AIHW). Health system expenditures on cancer and other neoplasms in Australia 2000–2001. AIHW cat. no. HWE 29. Health and Welfare Expenditure Series No. 22. Canberra: Australian Institute of Health and Welfare; 2005.Google Scholar
- 8.Oddone N, Gary J, Morgan GJ, et al. Metastatic cutaneous squamous cell carcinoma of the head and neck. The Immunosuppression, Treatment, Extranodal Spread, and Margin Status (ITEM) Prognostic Score to Predict Outcome and the Need to Improve Survival. Cancer. 2009;115:1883–91.CrossRefPubMedGoogle Scholar
- 26.Bischoff EPE. Microscopic analysis of the anastamosis between the cranial nerves. Hanover: University Press of New England; 1997. p. 1–138.Google Scholar
- 29.Grégoire V, Levendag P. CT-based delineation of lymph node levels in the N0 neck: DAHANCA, EORTC, GORTEC, RTOG consensus guidelines. http://www.rtog.org/LinkClick.aspx?fileticket=TjrmNiHXly8%3d&tabid=229. Accessed 16 June 2013.
- 34.Merkel PET Phase II ‘MP3’ Study (NCT01013779). http://www.trog.com.au/Portals/0/Open%20Trials/TROG%2009%2003_Amend%202%2010%20March%202011_Clean.pdf. Accessed 16 June 2013.
- 35.Nottage M, Francesconi A, Houston K, et al. A prospective study investigating the impact of definitive chemoradiation in locoregionally advanced squamous cell carcinoma of the skin. J Clin Oncol. 2012;30(suppl; abstr 8538).Google Scholar
- 36.Maubec E, Petrow P, Duvillard P, et al. Cetuximab as first-line monotherapy in patients with skin unresectable squamous cell carcinoma: final results of a phase II multicenter study. J Clin Oncol. 2010;28(suppl; abstr 8510).Google Scholar
- 37.Weber RS, Lustig RA, El-Naggar AK, et al. Gefitinib for advanced cutaneous squamous cell carcinoma of head and neck: phase II trial. J Clin Oncol. 2009;27(suppl; abstr 6054).Google Scholar